InVivo Therapeutics (NVIV) Stock Analysis

What InVivo Therapeutics does

InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold. This device is engineered to be implanted directly at the site of injury within the spinal cord, aiming to treat acute SCI. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.

Key metrics

ETFs linked to NVIV

Broad-market and Healthcare sector ETFs an investor holding InVivo Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NVIV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for InVivo Therapeutics?

InVivo Therapeutics trades under the ticker NVIV on NASDAQ.

Which exchange is NVIV listed on?

NVIV is listed on NASDAQ.

What sector does InVivo Therapeutics operate in?

InVivo Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NVIV in a portfolio?

PortView shows NVIV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.